{
  "schema_version": "0.1.0",
  "case_id": "HR-ML010",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML010",
    "display_name": "Billie Holiday",
    "aliases": [
      "Eleanora Fagan"
    ],
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1915-04-07",
          "display": "April 7, 1915",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1915",
              "display": "1915",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1959-07-17",
          "display": "July 17, 1959",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1959",
              "display": "1959",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          },
          {
            "date": {
              "iso": "1959-07-15",
              "display": "July 15, 1959",
              "precision": "day",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0004"
            ],
            "resolution_status": "conflicting",
            "note": "One encyclopedia entry gives July 15; PBS American Masters, Biography.com, and Clio give July 17."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML010-SYN",
      "ssn": "000-10-4472",
      "date_of_birth": "1993-04-07",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Constance Mayfield, MD",
      "fictional_consultant": {
        "name": "Julian Ortiz, MD",
        "specialty": "Addiction Medicine"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1915-04-07",
        "display": "April 7, 1915",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born Eleanora Fagan in Philadelphia; raised in Baltimore.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1943",
        "display": "about 1943",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Began using heroin.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1945-10",
        "display": "October 1945",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Her mother died; her drinking and drug use increased.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1947-05-16",
        "display": "May 16, 1947",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Arrested for narcotics possession; sentenced to a year and a day.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1948-03-16",
        "display": "March 16, 1948",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Released early from federal custody; lost her New York cabaret card.",
      "claim_ids": [
        "CLM-0004",
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1950",
        "display": "1950",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Drinking increased over the following seven years.",
      "claim_ids": [
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1956",
        "display": "1956",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Lady Sings the Blues published.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1959-07-17",
        "display": "July 17, 1959",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died at Metropolitan Hospital in New York.",
      "claim_ids": [
        "CLM-0009"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Billie Holiday was born Eleanora Fagan in Philadelphia on April 7, 1915, and was raised in Baltimore by her mother, Sarah Julia \"Sadie\" Fagan.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "birth registration in Philadelphia"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "Her mother died in October 1945; afterwards Holiday drank more heavily and her drug use increased as she grieved.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the synthetic alcohol use disorder. The cause of her mother's death is not given in the cited sources.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Her mother Sadie died October 6, 1945"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "addiction severe after her mother's death"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0003",
      "statement": "Holiday began using heroin in the early 1940s, and her addiction became severe in the late 1940s; she was arrested repeatedly over her heroin use in that period.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the synthetic opioid use disorder. The arrests are recorded as part of her history, without judgment.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "became addicted to heroin during 1943 and 1944"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0004",
      "statement": "In May 1947 Holiday was arrested for narcotics possession; she pleaded guilty, was sentenced to a year and a day, and was held at the federal facility for women at Alderson, West Virginia, until her early release on March 16, 1948.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Release after a long period of enforced abstinence carries a high risk of overdose; the modern episode begins five weeks after her release. One source names the place as \"Alderston, Virginia,\" an evident error.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "one year and a day"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0005",
      "statement": "Holiday sought treatment for her addiction, at one point checking herself into an institution in the hope of breaking her habit.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Supports her own wish to recover, which the episode builds on. The source gives no date.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0006",
      "statement": "Her conviction cost her the New York City cabaret card she needed to perform in clubs that served alcohol.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "A loss of income and work tied to the conviction; part of her social history.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "denied a license to perform in establishments that sold alcohol"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "The Federal Bureau of Narcotics pursued Holiday for years, and later writers have described that pursuit as driven by racism and linked it to her performance of \"Strange Fruit,\" a song against lynching.",
      "evidence_grade": "R",
      "certainty": "probable",
      "clinical_interpretation": "Retrospective interpretation by later writers; recorded to support trauma-informed care, and not used to state any person's motives as fact.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0008",
      "statement": "Her autobiography, Lady Sings the Blues, written in collaboration with William Dufty, was published in 1956.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the index date; not quoted in the record.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "ghosted autobiography"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "In 1959 Holiday was admitted to Metropolitan Hospital in New York with liver and heart problems and was diagnosed with cirrhosis. While she was in the hospital she was arrested for narcotics possession and kept under police guard. She died there on July 17, 1959, aged 44; the cause of death is given as cirrhosis of the liver with pulmonary edema, or pulmonary edema and heart failure.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the episode, recorded as a fact without detail. The episode records no liver diagnosis. One source dates her death to July 15, 1959.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "admitted to the hospital for heart and liver problems"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died July 17, 1959"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "disputes",
          "locator": "gives July 15, 1959"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0010",
      "statement": "After 1950 she slipped deeper into alcohol use over the following seven years.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the index date; supports the decision to treat her alcohol use from the start of the episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Billie Holiday: About the Performer",
      "publisher": "PBS American Masters (WNET)",
      "url": "https://www.pbs.org/wnet/americanmasters/billie-holiday-about-the-performer/68/",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-03",
      "rights_note": "Public broadcaster biography page; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Billie Holiday",
      "publisher": "Biography.com (A&E Television Networks)",
      "url": "https://www.biography.com/musicians/billie-holiday",
      "source_type": "other",
      "published": "2014-04-03",
      "accessed": "2026-11-03",
      "rights_note": "Reference biography, last updated November 12, 2021; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Billie Holiday Historical Marker",
      "publisher": "Clio (African American History of Philadelphia Heritage Trail, Saint Vincent College)",
      "url": "https://theclio.com/tour/714/4",
      "source_type": "scholarly",
      "published": "2021-05",
      "accessed": "2026-11-03",
      "rights_note": "University-produced heritage-trail entry; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Nicholson S. Holiday, Billie",
      "publisher": "Jazz.com encyclopedia",
      "url": "https://jazz.com/encyclopedia/holiday-billie",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-03",
      "rights_note": "Encyclopedia entry by a Holiday biographer; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Chang R. Billie Holiday and the U.S. government's war on narcotics",
      "publisher": "Biography.com (A&E Television Networks)",
      "url": "https://www.biography.com/musicians/billie-holiday-narcotics-us-government",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-03",
      "rights_note": "Feature article drawing on a journalist's book; used only for the retrospective interpretation in CLM-0007."
    },
    {
      "source_id": "SRC-0006",
      "title": "Adams J. Lady Day departs into that good night",
      "publisher": "The Globe and Mail",
      "url": "https://www.theglobeandmail.com/multimedia/lady-day-departs-into-that-good-night/article19633469",
      "source_type": "other",
      "published": "2014-07-17",
      "accessed": "2026-11-03",
      "rights_note": "Newspaper retrospective; facts used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-03",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-04-20",
    "index_age": 33,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Evidence-based, non-stigmatizing, trauma-informed primary care for a 33-year-old singer with a severe opioid use disorder and a moderate alcohol use disorder, five weeks after release from custody, when overdose risk is highest: starting buprenorphine in primary care, naloxone and overdose education, acamprosate for alcohol because naltrexone cannot be combined with buprenorphine, PEth to follow drinking, hepatitis, HIV, and liver screening with FIB-4 fibrosis staging, hepatitis A and B vaccination, depression screening with a structured safety assessment and the 988 Suicide & Crisis Lifeline, and an integrated recovery plan that continues medication through a return to use rather than requiring linear recovery, on the ASAM, SAMHSA, VA/DoD, and AASLD guidance and the CMID depression monograph.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-04-20",
        "purpose": "Establishing primary care five weeks after release from custody: medication for opioid use disorder, overdose prevention, alcohol care, liver and infection screening, and depression and safety screening"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-04-27",
        "purpose": "One-week buprenorphine check and addiction medicine consultation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-05-26",
        "purpose": "Five-week recovery review and second hepatitis B vaccine"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-07-20",
        "purpose": "Three-month review after a return to opioid use: adjusting the recovery plan"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-08-31",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-09-21",
        "purpose": "Same-day sick visit for a dental abscess"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-19",
        "purpose": "Six-month recovery, alcohol, liver, and mood review"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Opioid use disorder (heroin), severe; in early remission in a controlled environment at intake, five weeks after release from custody; on buprenorphine; synthetic modern episode linked to her documented heroin use",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F11.20",
            "display": "Opioid dependence, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern coding of the documented heroin addiction; language is person-first, and the code does not change with a return to use.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Alcohol use disorder, moderate; synthetic modern episode linked to her documented heavier drinking after her mother's death",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F10.20",
            "display": "Alcohol dependence, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic modern coding of the documented drinking; the liver disease reported in her last year is not coded, because it was documented long after the episode.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-003",
        "display": "Acute periapical abscess of the lower right first molar with localized swelling, treated with an antibiotic and dental drainage; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K04.7",
            "display": "Periapical abscess without sinus",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic acute dental infection; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-09-21"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Buprenorphine 8 mg and naloxone 2 mg sublingual film: half a film (4 mg) on day 1, then one film (8 mg) under the tongue daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1010604",
            "display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Film",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "sublingual",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One film under the tongue daily after a 4 mg first dose"
        },
        "start_date": "2026-04-20",
        "end_date": "2026-04-27",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic start of medication for opioid use disorder; with no recent opioid use and no withdrawal, a low first dose was used because her tolerance had fallen.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Buprenorphine 8 mg and naloxone 2 mg sublingual film, two films (16 mg) under the tongue once daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1010604",
            "display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Film",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "sublingual",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Two films under the tongue once daily"
        },
        "start_date": "2026-04-27",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic dose increase for continuing cravings at 8 mg; continued without interruption through a return to use.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Naloxone 4 mg nasal spray, one spray in one nostril for a suspected opioid overdose; may repeat every 2 to 3 minutes in alternating nostrils; call 911",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1725059",
            "display": "naloxone hydrochloride 40 MG/ML Nasal Spray",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 0.1,
          "unit": "mL"
        },
        "route": "nasal",
        "frequency": {
          "period": 3,
          "period_unit": "min",
          "text": "One spray (4 mg) in one nostril for suspected overdose; repeat every 2 to 3 minutes if there is no response"
        },
        "start_date": "2026-04-20",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic rescue medicine; two two-packs, one for home and one for her bag, with training for her and the people around her.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "as_needed": true
      },
      {
        "id": "MED-004",
        "display": "Acamprosate 333 mg delayed-release oral tablet, two tablets (666 mg) by mouth three times daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "835726",
            "display": "acamprosate calcium 333 MG Delayed Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "Two tablets by mouth three times daily"
        },
        "start_date": "2026-04-27",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic medication for alcohol use disorder chosen because naltrexone cannot be used with buprenorphine; kidney function normal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Thiamine 100 mg oral tablet, one tablet by mouth daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "313323",
            "display": "thiamine 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-04-20",
        "end_date": "2026-10-19",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic thiamine supplement for heavy alcohol use; stopped at six months when drinking was light.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Amoxicillin 500 mg oral capsule, one capsule by mouth three times daily for seven days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "308191",
            "display": "amoxicillin 500 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One capsule by mouth three times daily for seven days"
        },
        "start_date": "2026-09-21",
        "end_date": "2026-09-28",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic antibiotic for a periapical abscess with swelling and a low-grade temperature, until dental drainage.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Ibuprofen 400 mg oral tablet, one tablet by mouth every 6 to 8 hours with food as needed for tooth pain, for up to five days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197805",
            "display": "ibuprofen 400 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "One tablet by mouth every 6 to 8 hours with food as needed, up to five days"
        },
        "start_date": "2026-09-21",
        "end_date": "2026-09-26",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "as_needed": true,
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic non-opioid analgesic; short course with food because of her alcohol use.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for tooth pain, no more than 3,000 mg a day, for up to five days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "Two tablets by mouth every 8 hours as needed, up to 3,000 mg a day"
        },
        "start_date": "2026-09-21",
        "end_date": "2026-09-26",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "as_needed": true,
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic non-opioid analgesic combined with ibuprofen; daily limit lowered because of her alcohol use.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 12.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 11.6,
          "high": 15.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic blood count; macrocytosis consistent with heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V1",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 101,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic blood count; macrocytosis consistent with heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 236,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic blood count; macrocytosis consistent with heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 4.0,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 0.72,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 113,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 88,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 52,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests: AST above ALT and a raised GGT, consistent with alcohol; FIB-4 low.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 38,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests: AST above ALT and a raised GGT, consistent with alcohol; FIB-4 low.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V1",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 84,
        "unit": "U/L",
        "reference_range": {
          "low": 5,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests: AST above ALT and a raised GGT, consistent with alcohol; FIB-4 low.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 4.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests: AST above ALT and a raised GGT, consistent with alcohol; FIB-4 low.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 0.7,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests: AST above ALT and a raised GGT, consistent with alcohol; FIB-4 low.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HCV-V1",
        "display": "Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay",
        "label": "Hepatitis C antibody (signal-to-cutoff)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 0.09,
        "unit": "{s_co_ratio}",
        "reference_range": {
          "high": 0.99,
          "text": "Below 1.00 is nonreactive"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "48159-8",
            "display": "Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis C antibody screen, nonreactive.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HBSAB-V1",
        "display": "Hepatitis B virus surface Ab [Units/volume] in Serum",
        "label": "Hepatitis B surface antibody",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 3,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 10
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "16935-9",
            "display": "Hepatitis B virus surface Ab [Units/volume] in Serum",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B surface antibody, not immune; surface antigen and core antibody nonreactive.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V1",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "Phosphatidylethanol (PEth)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 312,
        "unit": "ng/mL",
        "reference_range": {
          "high": 19,
          "text": "Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic PEth level consistent with heavy drinking in the past two to four weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-04-20",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; mild symptoms; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-04-20",
        "value": 8,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic alcohol screen; positive.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-DAST10-V1",
        "display": "Total score [DAST-10]",
        "label": "DAST-10",
        "status": "final",
        "effective_date": "2026-04-20",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "82667-7",
            "display": "Total score [DAST-10]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic drug-use screen for the past 12 months; substantial problems.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-26",
        "value": 38,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests five weeks after starting acamprosate; improving.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-26",
        "value": 30,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests five weeks after starting acamprosate; improving.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V3",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-26",
        "value": 52,
        "unit": "U/L",
        "reference_range": {
          "low": 5,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests five weeks after starting acamprosate; improving.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V3",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "Phosphatidylethanol (PEth)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-26",
        "value": 96,
        "unit": "ng/mL",
        "reference_range": {
          "high": 19,
          "text": "Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic PEth level; drinking reduced but not stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-05-26",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 44,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests after heavier drinking on tour.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 33,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests after heavier drinking on tour.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V4",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 61,
        "unit": "U/L",
        "reference_range": {
          "low": 5,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests after heavier drinking on tour.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V4",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "Phosphatidylethanol (PEth)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 164,
        "unit": "ng/mL",
        "reference_range": {
          "high": 19,
          "text": "Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic PEth level; drinking increased during the tour.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-20",
        "value": 11,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 after a return to use and a stressful tour; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V6",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-31",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at the preventive visit; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V6",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-08-31",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic alcohol screen, below the risk threshold for women.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 12.9,
        "unit": "g/dL",
        "reference_range": {
          "low": 11.6,
          "high": 15.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; macrocytosis resolved.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V5",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 95,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; macrocytosis resolved.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 248,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; macrocytosis resolved.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 30,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests, normal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 26,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests, normal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V5",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 34,
        "unit": "U/L",
        "reference_range": {
          "low": 5,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests, normal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V5",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "Phosphatidylethanol (PEth)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 22,
        "unit": "ng/mL",
        "reference_range": {
          "high": 19,
          "text": "Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic PEth level, just above the abstinence threshold: light, occasional drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-19",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; remission of symptoms; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Advance care planning conversation, about 16 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-08-31",
          "end": "2026-08-31"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning at the preventive visit; no specific treatment preference is recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2026-04-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic booster; no dose on record.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 1 of 2",
        "status": "completed",
        "date": "2026-04-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination for an adult who is not immune and who has used drugs.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Hepatitis A vaccine, adult, dose 1 of 2",
        "status": "completed",
        "date": "2026-04-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "52",
            "display": "Hep A, adult",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis A vaccination recommended for people who use drugs.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-04-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose recommended for adults aged 19 to 49 with alcohol use disorder.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 2 of 2",
        "status": "completed",
        "date": "2026-05-26",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose at least four weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Hepatitis A vaccine, adult, dose 2 of 2",
        "status": "completed",
        "date": "2026-10-19",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "52",
            "display": "Hep A, adult",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose six months after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Influenza vaccine, 2026-2027 season",
        "status": "completed",
        "date": "2026-10-19",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly inactivated influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "MTH",
          "display": "mother"
        },
        "condition": "Died in 1945; cause not recorded in the cited source",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Heroin use from the early 1940s, becoming a severe addiction in the late 1940s; sought treatment for it at least once",
        "historical_date": {
          "iso": "1943",
          "display": "about 1943",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Heavier drinking and increased drug use after her mother's death",
        "historical_date": {
          "iso": "1945-10",
          "display": "October 1945",
          "precision": "month",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Federal custody after a narcotics possession conviction, about ten months with enforced abstinence; released early",
        "historical_date": {
          "iso": "1948-03-16",
          "display": "March 16, 1948",
          "precision": "day",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Establishing primary care five weeks after release from custody: medication for opioid use disorder, overdose prevention, alcohol care, liver and infection screening, and depression and safety screening",
        "status": "finished",
        "date": "2026-04-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "One-week buprenorphine check and addiction medicine consultation",
        "status": "finished",
        "date": "2026-04-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "One-week buprenorphine check, seen the same day by addiction medicine",
          "hpi": {
            "narrative": "Ms. Holiday returns one week after starting buprenorphine with naloxone and is seen by Dr. Ortiz of addiction medicine on the same day. She took half a film on the first day and one film daily since, under the tongue each morning, without missing a dose. She has used no heroin or other opioids. She had no withdrawal, but cravings come back each evening, most of all after a show. She has had mild constipation and no drowsiness. She picked up two naloxone two-packs; her friend came with her and was shown how to use them. She is still drinking four or five drinks on performance nights. She read her results from last week by phone. She says she came back because nobody lectured her at the first visit.",
            "elements": [
              {
                "label": "Buprenorphine",
                "value": "8 mg daily for six days, every dose taken"
              },
              {
                "label": "Opioid use",
                "value": "None"
              },
              {
                "label": "Cravings",
                "value": "Every evening, strongest after shows"
              },
              {
                "label": "Side effects",
                "value": "Mild constipation"
              },
              {
                "label": "Naloxone",
                "value": "Two two-packs dispensed; her friend trained"
              },
              {
                "label": "Alcohol",
                "value": "Four or five drinks on performance nights"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No sweats, chills, or drowsiness"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Mild constipation; no nausea, vomiting, or abdominal pain"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Evening cravings; mood low at times; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Alert and engaged; blood pressure 122/78, pulse 78"
            },
            {
              "system": "Eyes",
              "finding": "Pupils normal in size; no yawning, tearing, or gooseflesh"
            },
            {
              "system": "Psychiatric",
              "finding": "Calm; no signs of intoxication or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Opioid use disorder on buprenorphine",
              "assessment": "No opioid use, but cravings persist at 8 mg. Urine test today shows buprenorphine and its metabolite and no fentanyl or other opioids. Dr. Ortiz agrees with increasing the dose. Safety reviewed: no thoughts of suicide or self-harm; naloxone in place",
              "plan": [
                "Increase buprenorphine with naloxone to 16 mg (two films) once daily",
                "Fiber, fluids, and a stool softener as needed for constipation",
                "Weekly counseling and a peer recovery coach, as she chose today"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder",
              "assessment": "Drinking unchanged. Naltrexone cannot be used with buprenorphine; kidney function is normal (creatinine 0.72 mg/dL), so acamprosate is suitable",
              "plan": [
                "Start acamprosate 666 mg three times daily",
                "Continue thiamine",
                "PEth and liver tests at the next visit"
              ]
            },
            {
              "display": "Screening results",
              "assessment": "Hepatitis C antibody nonreactive (signal-to-cutoff 0.09); hepatitis B surface antigen and core antibody nonreactive, and surface antibody 3 mIU/mL, so she is not immune; HIV antigen-antibody test nonreactive. AST 52 and GGT 84 U/L with ALT 38, consistent with alcohol; albumin 4.0 g/dL and bilirubin 0.7 mg/dL normal; FIB-4 1.18, below 1.3, which makes advanced fibrosis unlikely",
              "plan": [
                "Second hepatitis B vaccine dose at the next visit",
                "Repeat liver tests with PEth"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Buprenorphine dose, adherence, cravings, withdrawal, and side effects",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "8 mg daily, every dose taken; evening cravings; no withdrawal or sedation; increased to 16 mg",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Visit frequency",
              "cadence": "Every 1 to 2 weeks in the first month after starting, then every 2 to 4 weeks until stable",
              "status": "completed_today",
              "detail": "Seen one week after starting",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine drug testing, including fentanyl, explained as part of care rather than as a test of trust",
              "cadence": "At the start, then about monthly early in treatment and as needed",
              "status": "completed_today",
              "detail": "Buprenorphine and norbuprenorphine present; no fentanyl or other opioids",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription drug monitoring program check",
              "cadence": "Before each buprenorphine prescription",
              "status": "completed_today",
              "detail": "No other controlled-substance prescriptions",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone at home and in her bag, and a trained companion",
              "cadence": "At the start; check and replace at each visit",
              "status": "completed_today",
              "detail": "Two two-packs dispensed; her friend trained",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Overdose prevention: never using alone and fentanyl test strips",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Reviewed; fentanyl test strips given",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Counseling and peer recovery support",
              "cadence": "Offered to everyone; not a condition of medication",
              "status": "completed_today",
              "detail": "She chose weekly counseling and a peer recovery coach",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Oral care on sublingual buprenorphine",
              "cadence": "At the start and yearly",
              "status": "completed_today",
              "detail": "After the film dissolves, swish water and swallow, and wait an hour before brushing; dental visit advised",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking and PEth",
              "cadence": "PEth at intake and at each check while drinking continues; AUDIT-C yearly",
              "status": "up_to_date",
              "detail": "PEth 312 ng/mL and AUDIT-C 8 a week ago; four or five drinks on performance nights",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Acamprosate adherence and kidney function",
              "cadence": "Kidney function before starting; adherence every visit",
              "status": "completed_today",
              "detail": "Creatinine 0.72 mg/dL and eGFR 113 a week ago; acamprosate started",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naltrexone for alcohol use disorder",
              "cadence": "First-line for alcohol use disorder unless opioids are needed",
              "status": "not_indicated",
              "detail": "Contraindicated with buprenorphine",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Alcohol withdrawal risk",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No history of withdrawal seizures or delirium; no withdrawal symptoms",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Thiamine",
              "cadence": "While drinking heavily",
              "status": "completed_today",
              "detail": "Taking thiamine 100 mg daily",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (AST, ALT, GGT, albumin, bilirubin)",
              "cadence": "At intake, then every 1 to 3 months while drinking is heavy, and yearly",
              "status": "up_to_date",
              "detail": "AST 52, ALT 38, GGT 84 U/L a week ago; albumin and bilirubin normal",
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "FIB-4 fibrosis score",
              "cadence": "At intake; repeat in 6 to 12 months with ongoing drinking, and every 1 to 2 years",
              "status": "up_to_date",
              "detail": "1.18 a week ago (age 33, AST 52, ALT 38, platelets 236): low risk",
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Vibration-controlled transient elastography",
              "cadence": "If FIB-4 is 1.3 or higher",
              "status": "not_indicated",
              "detail": "FIB-4 below 1.3",
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis C, hepatitis B, and HIV testing",
              "cadence": "At entry to care, then yearly while any drug use continues",
              "status": "up_to_date",
              "detail": "All nonreactive a week ago",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020",
                "GL-USPSTF-HIV-2019",
                "GL-CDC-HBV-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Hepatitis A and B vaccines",
              "cadence": "Hepatitis B two doses 4 weeks apart; hepatitis A two doses 6 months apart",
              "status": "up_to_date",
              "detail": "First doses a week ago; hepatitis B dose 2 next visit",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At intake and at each recovery visit while symptoms are present",
              "status": "up_to_date",
              "detail": "PHQ-9 9 a week ago; next at the five-week visit",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide and overdose risk review, safety plan, and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; overdose risk lowered by buprenorphine and naloxone; the 988 Suicide & Crisis Lifeline saved in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Pregnancy test and contraception",
              "cadence": "Before starting buprenorphine; contraception discussed",
              "status": "up_to_date",
              "detail": "Urine pregnancy test negative a week ago",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "referral",
              "measure": "Addiction medicine consultation",
              "cadence": "At the start of treatment",
              "status": "completed_today",
              "detail": "Seen by Dr. Ortiz today",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            }
          ],
          "follow_up": "Visit in two weeks; she leaves on tour in five days and will call in, with the in-person visit when she returns. Counselor weekly. Results by phone",
          "guideline_ids": [
            "GL-ASAM-OUD-2020",
            "GL-SAMHSA-MOUD",
            "GL-SUD-2021",
            "GL-AASLD-ALD-2019",
            "GL-AASLD-NIT-2025",
            "GL-SUICIDE-2024",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Five-week recovery review and second hepatitis B vaccine",
        "status": "finished",
        "date": "2026-05-26",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Five-week recovery review and second hepatitis B vaccine",
          "hpi": {
            "narrative": "Ms. Holiday returns five weeks after starting buprenorphine, after a three-week tour. She has taken 16 mg every morning without a gap and has used no heroin or other opioids. Cravings are now brief and come mostly late at night after a show; she calls her peer recovery coach when they do. She takes acamprosate most days but sometimes forgets the midday dose. She has cut down to two or three drinks on performance nights. She spoke with her counselor by phone each week while away. Her mood is a little better. She kept the naloxone in her bag and has not needed it.",
            "elements": [
              {
                "label": "Buprenorphine",
                "value": "16 mg daily, no gaps"
              },
              {
                "label": "Opioid use",
                "value": "None"
              },
              {
                "label": "Cravings",
                "value": "Brief, late at night; she calls her peer coach"
              },
              {
                "label": "Alcohol",
                "value": "Two or three drinks on performance nights"
              },
              {
                "label": "Acamprosate",
                "value": "Most days; misses some midday doses"
              }
            ]
          },
          "ros": [
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Constipation settled; no nausea"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Mood somewhat low at times; no thoughts of suicide or self-harm"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No tremor or unsteadiness"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 118/76, pulse 74"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender; no liver enlargement"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged; no signs of intoxication or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Opioid use disorder on buprenorphine",
              "assessment": "Stable on 16 mg with no opioid use; urine test shows buprenorphine only. The four-week gap since the one-week visit was longer than advised early in treatment, but weekly counseling calls continued and no harm resulted. Safety reviewed: no thoughts of suicide or self-harm",
              "plan": [
                "Continue buprenorphine with naloxone 16 mg daily",
                "Video check-ins every two weeks between visits while she tours"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on acamprosate",
              "assessment": "PEth down from 312 to 96 ng/mL: drinking reduced, not stopped. AST 38, ALT 30, GGT 52 U/L, all improving. PHQ-9 7",
              "plan": [
                "Continue acamprosate; take the midday dose with lunch, with a phone reminder",
                "Her goal for now is no more than two drinks on performance nights and none on other days"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Buprenorphine dose, adherence, cravings, withdrawal, and side effects",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "16 mg daily without gaps; brief cravings; no sedation",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Visit frequency",
              "cadence": "Every 1 to 2 weeks in the first month after starting, then every 2 to 4 weeks until stable",
              "status": "deferred",
              "detail": "Four weeks since the one-week visit, longer than the one to two weeks advised in the first month, because she was on tour; the planned call-in visit at two weeks did not happen. Weekly counseling calls continued, and no harm resulted. Corrective action: video check-ins every two weeks between visits while touring",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine drug testing, including fentanyl, explained as part of care rather than as a test of trust",
              "cadence": "At the start, then about monthly early in treatment and as needed",
              "status": "completed_today",
              "detail": "Buprenorphine and norbuprenorphine only",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription drug monitoring program check",
              "cadence": "Before each buprenorphine prescription",
              "status": "completed_today",
              "detail": "No other prescriptions",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone at home and in her bag, and a trained companion",
              "cadence": "At the start; check and replace at each visit",
              "status": "completed_today",
              "detail": "In her bag and at home; not used",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Overdose prevention: never using alone and fentanyl test strips",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Reviewed",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Counseling and peer recovery support",
              "cadence": "Offered to everyone; not a condition of medication",
              "status": "completed_today",
              "detail": "Weekly counseling by phone on tour; peer coach by phone",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking and PEth",
              "cadence": "PEth at intake and at each check while drinking continues; AUDIT-C yearly",
              "status": "completed_today",
              "detail": "PEth 96 ng/mL, from 312; two or three drinks on performance nights",
              "observation_ids": [
                "OBS-PETH-V3"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Acamprosate adherence and kidney function",
              "cadence": "Kidney function before starting; adherence every visit",
              "status": "completed_today",
              "detail": "Missing some midday doses; reminder set",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Thiamine",
              "cadence": "While drinking heavily",
              "status": "completed_today",
              "detail": "Taking thiamine daily",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (AST, ALT, GGT, albumin, bilirubin)",
              "cadence": "At intake, then every 1 to 3 months while drinking is heavy, and yearly",
              "status": "completed_today",
              "detail": "AST 38, ALT 30, GGT 52 U/L, improving",
              "observation_ids": [
                "OBS-AST-V3",
                "OBS-ALT-V3",
                "OBS-GGT-V3"
              ],
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "FIB-4 fibrosis score",
              "cadence": "At intake; repeat in 6 to 12 months with ongoing drinking, and every 1 to 2 years",
              "status": "up_to_date",
              "detail": "1.18 at intake; repeat at six months",
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Vibration-controlled transient elastography",
              "cadence": "If FIB-4 is 1.3 or higher",
              "status": "not_indicated",
              "detail": "FIB-4 below 1.3",
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Hepatitis A and B vaccines",
              "cadence": "Hepatitis B two doses 4 weeks apart; hepatitis A two doses 6 months apart",
              "status": "completed_today",
              "detail": "Hepatitis B dose 2 given today; hepatitis A dose 2 at six months",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At intake and at each recovery visit while symptoms are present",
              "status": "completed_today",
              "detail": "PHQ-9 7, item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide and overdose risk review, safety plan, and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; safety plan and the 988 Suicide & Crisis Lifeline in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            }
          ],
          "follow_up": "Video check-ins every two weeks while touring. Three-month visit with PEth, liver tests, and the PHQ-9",
          "guideline_ids": [
            "GL-ASAM-OUD-2020",
            "GL-SAMHSA-MOUD",
            "GL-SUD-2021",
            "GL-AASLD-ALD-2019",
            "GL-AASLD-NIT-2025",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Three-month review after a return to opioid use: adjusting the recovery plan",
        "status": "finished",
        "date": "2026-07-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Three-month review after a return to opioid use six days ago",
          "hpi": {
            "narrative": "Ms. Holiday returns three months after starting buprenorphine. Eight days ago, on tour in another state, the pharmacy could not refill her buprenorphine because the insurer's prior authorization had lapsed. After two days without it she had withdrawal and strong cravings, and six days ago she used heroin twice. She tested the supply first and the fentanyl strip was positive; she used with her friend present and naloxone at hand, and she did not overdose. The pharmacy filled the prescription the next day, and she restarted buprenorphine that morning, after waiting until she felt withdrawal again as she had been taught; she has taken it daily since and has used no opioids for five days. She also drank more on the tour, most nights. She called the clinic as soon as she was home and wanted to be seen. She is ashamed and worried that she has lost her place in treatment. She has had no thoughts of suicide. She feels tired and low and has not been sleeping well.",
            "elements": [
              {
                "label": "Return to use",
                "value": "Heroin twice, six days ago, after two days without buprenorphine"
              },
              {
                "label": "Cause of the gap",
                "value": "Lapsed prior authorization while on tour"
              },
              {
                "label": "Safety",
                "value": "Tested the supply (fentanyl positive); used with her friend present and naloxone at hand; no overdose"
              },
              {
                "label": "Buprenorphine",
                "value": "Restarted five days ago at 16 mg daily, without precipitated withdrawal"
              },
              {
                "label": "Alcohol",
                "value": "Drinking most nights on tour"
              },
              {
                "label": "Mood",
                "value": "Tired, low, ashamed; PHQ-9 11; item 9 scored 0"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; weight down 1.2 kg; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, vomiting, or diarrhea now"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No injection-site redness or abscess"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low mood, poor sleep, and shame after the return to use; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but well; blood pressure 128/82, pulse 86"
            },
            {
              "system": "Skin",
              "finding": "No injection marks, redness, or abscess"
            },
            {
              "system": "Eyes",
              "finding": "Pupils normal in size; no signs of withdrawal"
            },
            {
              "system": "Psychiatric",
              "finding": "Tearful at first, then engaged in planning; no signs of intoxication"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Opioid use disorder on buprenorphine, after a brief return to use",
              "assessment": "A brief return to use caused by a gap in medication, not by a failure of treatment, managed safely with test strips, a companion, and naloxone. A return to use is an expected part of recovery for many people and is a reason to strengthen treatment, not to stop it. Urine test today shows buprenorphine and norfentanyl, which fits use six days ago. She keeps her place in treatment. Dr. Ortiz reviewed the plan by phone today and agrees. Safety reviewed: no thoughts of suicide or self-harm; overdose risk discussed openly",
              "plan": [
                "Continue buprenorphine with naloxone 16 mg daily",
                "Prior authorization renewed for twelve months; pharmacy chain that can fill in any state; prescription filled a week before each tour; a travel letter and the clinic number for any problem",
                "Extended-release monthly buprenorphine injection offered as a way to avoid pharmacy gaps; she would rather stay on films for now and will think about it",
                "Naloxone replaced; new test strips"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on acamprosate",
              "assessment": "PEth up from 96 to 164 ng/mL with heavier drinking on tour; AST 44, ALT 33, GGT 61 U/L",
              "plan": [
                "Continue acamprosate and thiamine",
                "Plan with her counselor for nights on tour: non-alcoholic drinks after shows and a call to her peer coach"
              ]
            },
            {
              "display": "Low mood after the return to use",
              "assessment": "PHQ-9 11. On interview, the low mood, poor sleep, and shame began with the return to use and the tour; she does not describe a depressive episode, and there is no history suggesting mania. No thoughts of suicide",
              "plan": [
                "Weekly in-person counseling now that she is home",
                "PHQ-9 again at the preventive visit in six weeks",
                "The safety plan reviewed and updated with her"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Buprenorphine dose, adherence, cravings, withdrawal, and side effects",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Gap of three days from a lapsed prior authorization, then restarted at 16 mg; no precipitated withdrawal",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Visit frequency",
              "cadence": "Every 1 to 2 weeks in the first month after starting, then every 2 to 4 weeks until stable",
              "status": "completed_today",
              "detail": "Video check-ins every two weeks kept since the five-week visit; seen in person within days of her call",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine drug testing, including fentanyl, explained as part of care rather than as a test of trust",
              "cadence": "At the start, then about monthly early in treatment and as needed",
              "status": "completed_today",
              "detail": "Buprenorphine, norbuprenorphine, and norfentanyl, consistent with what she reported",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription drug monitoring program check",
              "cadence": "Before each buprenorphine prescription",
              "status": "completed_today",
              "detail": "No other prescriptions",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone at home and in her bag, and a trained companion",
              "cadence": "At the start; check and replace at each visit",
              "status": "completed_today",
              "detail": "Not used; replaced with new test strips",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Overdose prevention: never using alone and fentanyl test strips",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "She tested the supply and used with a companion and naloxone; reinforced without judgment",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription continuity on tour (pharmacy, prior authorization, travel letter)",
              "cadence": "Before each tour",
              "status": "completed_today",
              "detail": "Prior authorization renewed for twelve months; national pharmacy chain; early fill and travel letter",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Counseling and peer recovery support",
              "cadence": "Offered to everyone; not a condition of medication",
              "status": "completed_today",
              "detail": "Weekly in-person counseling from now; peer coach",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking and PEth",
              "cadence": "PEth at intake and at each check while drinking continues; AUDIT-C yearly",
              "status": "completed_today",
              "detail": "PEth 164 ng/mL, up from 96, with heavier drinking on tour",
              "observation_ids": [
                "OBS-PETH-V4"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Acamprosate adherence and kidney function",
              "cadence": "Kidney function before starting; adherence every visit",
              "status": "completed_today",
              "detail": "Taking it; midday reminder working",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Thiamine",
              "cadence": "While drinking heavily",
              "status": "completed_today",
              "detail": "Taking thiamine daily",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (AST, ALT, GGT, albumin, bilirubin)",
              "cadence": "At intake, then every 1 to 3 months while drinking is heavy, and yearly",
              "status": "completed_today",
              "detail": "AST 44, ALT 33, GGT 61 U/L",
              "observation_ids": [
                "OBS-AST-V4",
                "OBS-ALT-V4",
                "OBS-GGT-V4"
              ],
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "FIB-4 fibrosis score",
              "cadence": "At intake; repeat in 6 to 12 months with ongoing drinking, and every 1 to 2 years",
              "status": "up_to_date",
              "detail": "1.18 at intake; repeat at six months",
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At intake and at each recovery visit while symptoms are present",
              "status": "completed_today",
              "detail": "PHQ-9 11, item 9 scored 0; interview does not show a depressive episode",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Mood Disorder Questionnaire",
              "cadence": "At the evaluation of a new depressive episode",
              "status": "not_indicated",
              "detail": "No depressive episode on interview and no history suggesting mania",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide and overdose risk review, safety plan, and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; overdose risk after the gap reviewed; the safety plan updated; the 988 Suicide & Crisis Lifeline in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            }
          ],
          "follow_up": "Weekly counseling. Preventive visit in six weeks with the PHQ-9. Call the clinic the same day if a refill fails or cravings rise",
          "guideline_ids": [
            "GL-ASAM-OUD-2020",
            "GL-SAMHSA-MOUD",
            "GL-SUD-2021",
            "GL-AASLD-ALD-2019",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Six-month recovery, alcohol, liver, and mood review",
        "status": "finished",
        "date": "2026-10-19",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Six-month recovery, alcohol, liver, and mood review",
          "hpi": {
            "narrative": "Ms. Holiday returns six months after starting buprenorphine. She has taken 16 mg every day since the return to use before the three-month visit and has used no heroin or other opioids for three months. The early refill and travel letter worked on her last tour. She drinks one drink on some performance nights and none otherwise. Her dental abscess was drained by the dentist the week of her sick visit, and the tooth has since had root canal treatment; she finished the amoxicillin and needed the pain tablets for only three days. She sleeps better and enjoys singing again. She sees her counselor weekly and her peer recovery coach every two weeks.",
            "elements": [
              {
                "label": "Opioid use",
                "value": "None for three months"
              },
              {
                "label": "Buprenorphine",
                "value": "16 mg daily, no gaps"
              },
              {
                "label": "Alcohol",
                "value": "One drink on some performance nights"
              },
              {
                "label": "Tooth",
                "value": "Abscess drained; root canal completed; no pain"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 4"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy better; weight up 1.6 kg"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No tooth pain or swelling"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 score 4; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 116/74, pulse 72"
            },
            {
              "system": "Mouth",
              "finding": "Treated lower right molar; no swelling"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; no liver enlargement"
            },
            {
              "system": "Psychiatric",
              "finding": "Bright and engaged; no signs of intoxication or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Opioid use disorder on buprenorphine",
              "assessment": "Three months without opioid use and six months of continuous treatment, including the return to use, which she came through safely. Urine test shows buprenorphine only. Safety reviewed: no thoughts of suicide or self-harm",
              "plan": [
                "Continue buprenorphine with naloxone 16 mg daily; visits every month",
                "Naloxone and test strips checked; both in date"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on acamprosate",
              "assessment": "PEth 22 ng/mL, from 312 at intake: light, occasional drinking, as she chose. AST 30, ALT 26, GGT 34 U/L, now normal. MCV 95, back to normal. FIB-4 0.78 (age 33, AST 30, ALT 26, platelets 248), low risk",
              "plan": [
                "Continue acamprosate for at least six more months, then review",
                "Stop thiamine now that drinking is light",
                "Liver tests and FIB-4 yearly"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Periapical abscess",
              "assessment": "Resolved after drainage and root canal treatment",
              "plan": [
                "Dental review every six months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Buprenorphine dose, adherence, cravings, withdrawal, and side effects",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "16 mg daily without gaps; no cravings this month",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Visit frequency",
              "cadence": "Every 1 to 2 weeks in the first month after starting, then every 2 to 4 weeks until stable",
              "status": "completed_today",
              "detail": "Stable; monthly visits from now",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine drug testing, including fentanyl, explained as part of care rather than as a test of trust",
              "cadence": "At the start, then about monthly early in treatment and as needed",
              "status": "completed_today",
              "detail": "Buprenorphine and norbuprenorphine only",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription drug monitoring program check",
              "cadence": "Before each buprenorphine prescription",
              "status": "completed_today",
              "detail": "Only the dental prescriptions from the sick visit, which were not opioids",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone at home and in her bag, and a trained companion",
              "cadence": "At the start; check and replace at each visit",
              "status": "completed_today",
              "detail": "In date at home and in her bag",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription continuity on tour (pharmacy, prior authorization, travel letter)",
              "cadence": "Before each tour",
              "status": "completed_today",
              "detail": "Early fill and travel letter worked on the last tour",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Counseling and peer recovery support",
              "cadence": "Offered to everyone; not a condition of medication",
              "status": "completed_today",
              "detail": "Counseling weekly; peer coach every two weeks",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD",
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Oral care on sublingual buprenorphine",
              "cadence": "At the start and yearly",
              "status": "completed_today",
              "detail": "Abscess treated; dental review every six months",
              "guideline_ids": [
                "GL-ASAM-OUD-2020",
                "GL-SAMHSA-MOUD"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking and PEth",
              "cadence": "PEth at intake and at each check while drinking continues; AUDIT-C yearly",
              "status": "completed_today",
              "detail": "PEth 22 ng/mL; AUDIT-C 3 at the preventive visit",
              "observation_ids": [
                "OBS-PETH-V5"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Acamprosate adherence and kidney function",
              "cadence": "Kidney function before starting; adherence every visit",
              "status": "completed_today",
              "detail": "Taking all three doses",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Thiamine",
              "cadence": "While drinking heavily",
              "status": "completed_today",
              "detail": "Stopped today; drinking is light",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (AST, ALT, GGT, albumin, bilirubin)",
              "cadence": "At intake, then every 1 to 3 months while drinking is heavy, and yearly",
              "status": "completed_today",
              "detail": "AST 30, ALT 26, GGT 34 U/L, normal",
              "observation_ids": [
                "OBS-AST-V5",
                "OBS-ALT-V5",
                "OBS-GGT-V5"
              ],
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count",
              "cadence": "At intake and with liver tests while drinking",
              "status": "completed_today",
              "detail": "Hemoglobin 12.9 g/dL, MCV 95 fL (from 101), platelets 248",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-MCV-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "FIB-4 fibrosis score",
              "cadence": "At intake; repeat in 6 to 12 months with ongoing drinking, and every 1 to 2 years",
              "status": "completed_today",
              "detail": "0.78, low risk; repeat yearly",
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Vibration-controlled transient elastography",
              "cadence": "If FIB-4 is 1.3 or higher",
              "status": "not_indicated",
              "detail": "FIB-4 below 1.3",
              "guideline_ids": [
                "GL-AASLD-ALD-2019",
                "GL-AASLD-NIT-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis C, hepatitis B, and HIV testing",
              "cadence": "At entry to care, then yearly while any drug use continues",
              "status": "due",
              "detail": "Nonreactive at intake; repeat at the intake anniversary",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020",
                "GL-USPSTF-HIV-2019",
                "GL-CDC-HBV-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Hepatitis A and B vaccines",
              "cadence": "Hepatitis B two doses 4 weeks apart; hepatitis A two doses 6 months apart",
              "status": "completed_today",
              "detail": "Hepatitis A dose 2 given today; both series complete",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Influenza vaccine",
              "cadence": "Each autumn",
              "status": "completed_today",
              "detail": "Given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At intake and at each recovery visit while symptoms are present",
              "status": "completed_today",
              "detail": "PHQ-9 4, from 9 at intake and 11 at three months",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide and overdose risk review, safety plan, and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            }
          ],
          "follow_up": "Monthly buprenorphine visits. Counseling weekly. Liver tests, FIB-4, and infection screening at one year",
          "guideline_ids": [
            "GL-ASAM-OUD-2020",
            "GL-SAMHSA-MOUD",
            "GL-SUD-2021",
            "GL-AASLD-ALD-2019",
            "GL-AASLD-NIT-2025",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-08-31",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient on paper in a private room and reviewed with her by Dr. Mayfield; kept in the confidential part of the record with her substance use treatment records",
          "hpi": {
            "narrative": "Ms. Holiday is a 33-year-old singer with a severe opioid use disorder on buprenorphine and a moderate alcohol use disorder on acamprosate, who comes for her yearly preventive visit six weeks after her three-month review. Since that visit, when the recovery plan was adjusted after a brief return to use on tour, she has taken buprenorphine every day without a gap and has used no heroin or other opioids. The pharmacy now fills her prescription before each tour, and she carries a travel letter. She drinks one or two drinks on some performance nights and none on most other days. She still carries naloxone and fentanyl test strips. She meets her counselor weekly and her peer recovery coach by phone. Her mood is better, and her PHQ-9 today is 6. She has no new concerns.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 33"
              },
              {
                "label": "Opioid use",
                "value": "None since the return to use before the three-month visit; buprenorphine daily without gaps"
              },
              {
                "label": "Alcohol",
                "value": "One or two drinks on some performance nights; AUDIT-C 3"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 6; item 9 scored 0"
              },
              {
                "label": "Medicines",
                "value": "Buprenorphine with naloxone 16 mg daily; acamprosate 666 mg three times daily; thiamine; naloxone spray on hand"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair, and better than in the spring"
            },
            {
              "domain": "Psychosocial",
              "finding": "Supported by long-time musicians, a close friend, her counselor, and a peer recovery coach; grief for her mother still returns at times"
            },
            {
              "domain": "Substance use",
              "finding": "No opioid use for six weeks on buprenorphine; AUDIT-C 3"
            },
            {
              "domain": "Tobacco",
              "finding": "About five cigarettes a day"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks most days; performing is physically demanding"
            },
            {
              "domain": "Nutrition",
              "finding": "Irregular meals on performance days; eating more regularly at home"
            },
            {
              "domain": "Sleep",
              "finding": "Six to seven hours, better than at intake"
            },
            {
              "domain": "Sexual and reproductive health",
              "finding": "Sexually active; uses condoms; not planning a pregnancy now"
            },
            {
              "domain": "Safety at home",
              "finding": "Feels safe at home; no one hurts or threatens her"
            },
            {
              "domain": "Road safety",
              "finding": "Wears a seat belt"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Oral health",
              "finding": "No dental visit in several years"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever, night sweats, or weight loss"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No vision change"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hoarseness or voice change; no dental pain"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal pain, vomiting, black stools, or yellowing of the skin; constipation settled with fiber"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No abnormal bleeding or discharge"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No skin infections or abscesses"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No numbness, tremor, or unsteadiness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood better; PHQ-9 score 6; no thoughts of suicide or self-harm; cravings occasional and manageable"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 68.8 kg, BMI 25.3; blood pressure 118/76"
            },
            {
              "system": "Eyes",
              "finding": "No scleral icterus"
            },
            {
              "system": "Mouth",
              "finding": "Several teeth with visible decay; no abscess"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement or nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender; liver edge not palpable; no spleen enlargement"
            },
            {
              "system": "Skin",
              "finding": "No spider angiomas, palmar erythema, track marks, or abscesses"
            },
            {
              "system": "Neurological",
              "finding": "No tremor; gait steady"
            },
            {
              "system": "Psychiatric",
              "finding": "Calm and engaged; no signs of intoxication or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. Cervical screening and sexual-health tests are due, and dental care is overdue",
              "plan": [
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Opioid use disorder on buprenorphine",
              "assessment": "Six weeks without opioid use since the plan was adjusted; no gaps in buprenorphine. Safety reviewed: no thoughts of suicide or self-harm; she has naloxone, test strips, and the 988 Suicide & Crisis Lifeline saved in her phone",
              "plan": [
                "Continue buprenorphine with naloxone 16 mg daily",
                "Six-month recovery review in seven weeks"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on acamprosate",
              "assessment": "Drinking much reduced; AUDIT-C 3",
              "plan": [
                "Continue acamprosate and thiamine; PEth and liver tests at six months"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "118/76 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "ordered",
              "detail": "No result on record; cytology with HPV testing collected today; every five years if normal",
              "guideline_ids": [
                "GL-USPSTF-CERV-2024"
              ]
            },
            {
              "service": "Chlamydia and gonorrhea screening",
              "status": "ordered",
              "detail": "Offered because of new partners in the past year; urine test today with her agreement",
              "guideline_ids": [
                "GL-USPSTF-STI-2021"
              ]
            },
            {
              "service": "Syphilis screening",
              "status": "ordered",
              "detail": "Offered with the other sexual-health tests; drawn today",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "HIV, hepatitis C, and hepatitis B screening",
              "status": "up_to_date",
              "detail": "All nonreactive at intake; repeat yearly while any drug use continues",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019",
                "GL-USPSTF-HCV-2020",
                "GL-CDC-HBV-2023"
              ]
            },
            {
              "service": "Pregnancy intention and contraception",
              "status": "completed_today",
              "detail": "Not planning a pregnancy; uses condoms; other methods discussed and she will think about them. Buprenorphine is safe to continue in pregnancy, and she was told so",
              "guideline_ids": [
                "GL-ASAM-OUD-2020"
              ]
            },
            {
              "service": "Intimate partner violence screening",
              "status": "completed_today",
              "detail": "Negative; she feels safe at home",
              "guideline_ids": [
                "GL-USPSTF-IPV-2018"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-9 score 6, down from 11 six weeks ago; item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C score 3, from 8 at intake; in treatment",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco cessation",
              "status": "declined",
              "detail": "About five cigarettes a day; nicotine replacement and counseling offered; she is not ready and will say when she is",
              "guideline_ids": [
                "GL-USPSTF-TOB-2021"
              ]
            },
            {
              "service": "Diabetes and cholesterol screening",
              "status": "not_indicated",
              "detail": "Diabetes screening begins at 35 for adults who are overweight; statin assessment begins at 40",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Breast and colorectal cancer screening",
              "status": "not_indicated",
              "detail": "Begin at 40 and 45",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Hepatitis A vaccine",
              "status": "due",
              "detail": "Dose 2 at the six-month visit",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "up_to_date",
              "detail": "Two-dose series complete",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 at intake, recommended for adults with alcohol use disorder",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap at intake",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Influenza and COVID-19 vaccines, this season",
              "status": "due",
              "detail": "Influenza vaccine at the six-month visit; COVID-19 vaccine discussed and she will decide then",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "HPV vaccine",
              "status": "declined",
              "detail": "Shared decision-making for adults 27 to 45; she chose not to have it",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Dental examination",
              "status": "referred",
              "detail": "Visible decay and no dental visit in several years; dry mouth from buprenorphine discussed; dental appointment arranged",
              "guideline_ids": [
                "GL-ASAM-OUD-2020"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 16 minutes, with her consent. She named a health care agent, and a health care proxy form was completed; the agent is recorded in the confidential part of the chart and is not named here. She said that what matters most to her is her music, being treated with respect, and deciding for herself who learns about her health. She chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness.",
          "follow_up": "Six-month recovery review in seven weeks, with PEth, liver tests, blood count, the second hepatitis A dose, and the influenza vaccine. Sexual-health and cervical screening results by phone, as she asked. Dental appointment arranged. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-CMID-2026",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Same-day sick visit for a dental abscess",
        "status": "finished",
        "date": "2026-09-21",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Tooth pain and swelling of the lower right jaw for two days",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Ms. Holiday asked for a same-day visit for pain in a lower right back tooth. The tooth has been sensitive for weeks; two days ago it became a constant throbbing pain, and since yesterday the gum beside it has been swollen. The pain kept her awake last night and is worse with chewing and hot drinks. She felt warm last night but has had no chills. She can open her mouth fully and swallow normally, and she has no swelling under the tongue or down the neck and no trouble breathing. Her dental appointment is still three weeks away. She has taken her usual buprenorphine 16 mg each morning and no other medicine. She came in because she was frightened that the pain would push her toward heroin or toward drinking to get through a show this weekend; she has used neither and called her peer recovery coach last night.",
            "elements": [
              {
                "label": "Onset",
                "value": "Sensitivity for weeks; constant pain for two days"
              },
              {
                "label": "Location",
                "value": "Lower right back tooth and the gum beside it"
              },
              {
                "label": "Duration",
                "value": "Two days of constant pain; one day of swelling"
              },
              {
                "label": "Character",
                "value": "Throbbing"
              },
              {
                "label": "Severity",
                "value": "8 of 10 at worst; kept her awake"
              },
              {
                "label": "Timing",
                "value": "Constant, worse with chewing"
              },
              {
                "label": "Context",
                "value": "Untreated decay found at the preventive visit; dental appointment pending"
              },
              {
                "label": "Modifying factors",
                "value": "Worse with chewing and hot drinks; no medicine taken besides her buprenorphine"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Felt warm last night; no chills, trouble opening the mouth, trouble swallowing, neck swelling, or breathlessness. Worried about cravings; no opioid or alcohol use"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Felt warm last night; no chills or rigors"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Lower right tooth pain and gum swelling; no trouble swallowing, no voice change, no sore throat"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No breathlessness"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Worried that the pain would trigger cravings; no opioid or alcohol use; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Uncomfortable but not ill-appearing; temperature 37.6 °C, pulse 92, blood pressure 130/82"
            },
            {
              "system": "Mouth",
              "finding": "Deep decay in the lower right first molar, very tender to tapping, with a fluctuant gum swelling about 1 cm beside it; mouth opens fully; floor of the mouth soft; uvula midline"
            },
            {
              "system": "Face and neck",
              "finding": "Mild swelling over the right lower jaw; one tender lymph node below the jaw; no spreading redness, no neck swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Breathing comfortably; clear to auscultation"
            },
            {
              "system": "Psychiatric",
              "finding": "Anxious but engaged; no signs of intoxication or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Acute periapical abscess, lower right first molar",
              "assessment": "Localized dental abscess with swelling and a low-grade temperature, without signs of spreading infection or airway risk. Definitive treatment is dental drainage; an antibiotic is appropriate because of the swelling and temperature until the dentist can drain it",
              "plan": [
                "Amoxicillin 500 mg three times daily for seven days",
                "Dental appointment moved to this week by phone, with her agreement, for drainage or root canal treatment",
                "Go to the emergency department for trouble swallowing or breathing, swelling under the tongue or down the neck, or a high fever"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Opioid use disorder on buprenorphine: acute pain",
              "assessment": "Acute pain in a person on buprenorphine is treated without stopping it. Buprenorphine continues at the same daily dose, and scheduled ibuprofen with acetaminophen relieves dental pain better than an opioid. No full-agonist opioid is needed. Safety reviewed: no thoughts of suicide or self-harm; naloxone and the 988 Suicide & Crisis Lifeline are in her phone and bag",
              "plan": [
                "Continue buprenorphine with naloxone 16 mg daily",
                "Ibuprofen 400 mg every 6 to 8 hours with food and acetaminophen 1,000 mg every 8 hours, no more than 3,000 mg a day because of her alcohol use, both for up to five days",
                "Her peer recovery coach and counselor told, with her consent, that she is in pain this week"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on acamprosate",
              "assessment": "No alcohol since the pain began; alcohol would add to the stomach risk of ibuprofen and the liver risk of acetaminophen",
              "plan": [
                "No alcohol while taking ibuprofen and acetaminophen; continue acamprosate"
              ]
            }
          ],
          "follow_up": "Dental drainage this week. Phone check in two days. Six-month recovery review as scheduled",
          "guideline_ids": [
            "GL-ADA-ABX-2019",
            "GL-ASAM-OUD-2020",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the infection is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-04-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 68.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 25.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-04-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 68.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 25.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-05-26",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 68.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 25.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-07-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 67.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 24.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 86,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-19",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 69.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 25.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 116,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-08-31",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 68.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 25.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-09-21",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 165,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 68.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 25.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 130,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 92,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit: low-grade temperature and a faster pulse with pain.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Professional singer; returned to concert work and touring after her release; can no longer work in clubs in her home city because of a licensing rule tied to her conviction",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented career and the loss of her cabaret card.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Returned home five weeks ago after about ten months in federal custody on a narcotics possession charge; no medication for opioid use disorder was offered there, and she has used no opioids since release",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic modern reentry history anchored to her documented sentence; written without judgment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Alcohol: four or five drinks on most performance nights since release (AUDIT-C 8); drinks to calm her nerves before and after shows",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic modern alcohol history anchored to her documented drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Tobacco: about five cigarettes a day; not ready to stop now and knows help is available",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic tobacco history; no tobacco diagnosis is coded.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Supports: musicians she has worked with for years, a close friend who has agreed to carry naloxone, and a peer recovery coach; her music is her strongest source of purpose",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic strengths and recovery supports.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Has repeatedly been singled out by law enforcement and feels watched; wary of clinics and of anything written about her. Confidentiality under the federal substance use disorder privacy rule explained, and she decides what is shared",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic trauma-informed history linked to the retrospective account of the narcotics bureau's pursuit; it states no person's motives.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all activities; performing several nights a week; sleep broken since release",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, guarded at first and then candid; speech normal; no signs of intoxication or withdrawal",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood low and tired, with grief for her mother that still returns; PHQ-9 score 9 with item 9 scored 0; no thoughts of suicide or self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "safety_assessment": {
      "id": "SAFE-001",
      "date": "2026-04-20",
      "current_ideation": "absent",
      "intent": "absent",
      "plan": "absent",
      "access_reviewed": true,
      "protective_factors": [
        "Her music and her wish to keep performing",
        "A close friend and a peer recovery coach",
        "Her own wish to recover, which she has acted on before",
        "Engagement in primary care and treatment"
      ],
      "disposition": "Outpatient care. Overdose risk is high in the weeks after release because tolerance has fallen: naloxone for her and her friend, never using alone, testing any drug supply with fentanyl test strips, and buprenorphine started today. The 988 Suicide & Crisis Lifeline was given and saved in her phone, and a written safety plan was made with her. Safety reviewed at every visit",
      "provenance": {
        "evidence_grade": "S",
        "claim_ids": [
          "CLM-0003",
          "CLM-0004",
          "CLM-0005"
        ],
        "synthetic_reason": "Synthetic present-day structured safety assessment required by the substance use disorder codes; it records no current suicidal ideation and makes no claim about her real mental health.",
        "author": "The Human Record generator",
        "created": "2026-11-03T18:00:00-05:00"
      }
    },
    "consultation": {
      "referral": {
        "question": "Severe opioid use disorder and moderate alcohol use disorder in a 33-year-old singer, five weeks after release from about ten months in custody, when her tolerance is low and her overdose risk high. Buprenorphine with naloxone was started today. Please confirm the medication plan and dose, advise on a medicine for her drinking that is safe with buprenorphine, and help set the monitoring and recovery plan",
        "urgency": "Within one week, on the same day as her one-week primary care visit",
        "pertinent_history": "Heroin use since her twenties, becoming severe in the last few years; she has sought treatment before. No opioid use since release and no withdrawal today; no medication for opioid use disorder was offered in custody. Drinking four or five drinks on most performance nights since release (AUDIT-C 8; PEth 312 ng/mL); no history of withdrawal seizures or delirium. DAST-10 7. PHQ-9 9, item 9 scored 0; structured safety assessment shows no suicidal thoughts. Urine pregnancy test negative. Today: buprenorphine with naloxone, 4 mg today and then 8 mg daily; naloxone nasal spray; thiamine; Tdap, PCV20, and first doses of hepatitis A and B vaccines. Blood tests drawn today: AST 52, ALT 38, GGT 84 U/L, albumin 4.0 g/dL, bilirubin 0.7 mg/dL, MCV 101 fL, platelets 236, creatinine 0.72 mg/dL; hepatitis C antibody, hepatitis B triple panel, and HIV test sent. She has been singled out by law enforcement many times and is wary of clinics; she asks that she decide what is shared and with whom",
        "questions": [
          "Is buprenorphine the right medication for her, and what dose should we aim for?",
          "Which medicine for alcohol use disorder can she take with buprenorphine?",
          "How should we read her liver tests, and does she need more than FIB-4 to stage fibrosis?",
          "What monitoring do you advise, including urine drug testing and visit frequency?",
          "How should we respond if she returns to opioid use?"
        ]
      },
      "consultant_note": {
        "history": "Ms. Holiday, a 33-year-old singer, is seen at the request of Dr. Mayfield one week after starting buprenorphine with naloxone. She has taken every dose, 4 mg on the first day and 8 mg since, and has used no opioids. She has had no withdrawal, but cravings return each evening, especially after shows. She drinks four or five drinks on performance nights to calm her nerves. She has no history of withdrawal seizures or delirium. She sought treatment for heroin use years ago and says she wants to stay off it and keep singing. Her biggest fear is overdosing now that her tolerance is low. She tours often and worries about getting prescriptions filled on the road. She asked that this note be shared only with Dr. Mayfield",
        "data_reviewed": "Dr. Mayfield's intake note with the safety assessment, AUDIT-C, DAST-10, and PHQ-9. Last week's results: AST 52, ALT 38, GGT 84 U/L; albumin 4.0 g/dL; bilirubin 0.7 mg/dL; MCV 101 fL; platelets 236; creatinine 0.72 mg/dL; PEth 312 ng/mL; hepatitis C antibody nonreactive (0.09); hepatitis B surface antigen and core antibody nonreactive, surface antibody 3 mIU/mL; HIV antigen-antibody nonreactive. Today's urine drug test: buprenorphine and norbuprenorphine only. Prescription drug monitoring program: no other controlled-substance prescriptions",
        "exam": [
          {
            "system": "General",
            "finding": "Alert and engaged; blood pressure 122/78, pulse 78"
          },
          {
            "system": "Eyes",
            "finding": "Pupils normal in size; no tearing"
          },
          {
            "system": "Skin",
            "finding": "No injection-site changes or abscesses"
          },
          {
            "system": "Neurological",
            "finding": "No tremor"
          },
          {
            "system": "Psychiatric",
            "finding": "Calm and direct; no signs of intoxication or withdrawal"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-001",
            "display": "Opioid use disorder, severe, early in buprenorphine treatment",
            "assessment": "Buprenorphine is a good choice: it lowers the risk of overdose death, can be prescribed from primary care, and fits her touring better than daily methadone clinic attendance, which remains an option if buprenorphine does not control her cravings. Extended-release naltrexone would need a long opioid-free period and does not protect her if she loses tolerance and uses again. Starting at a low dose was right after enforced abstinence. Evening cravings at 8 mg mean the dose is too low; most people do best at 16 mg or more"
          },
          {
            "problem_id": "PRB-002",
            "display": "Alcohol use disorder, moderate",
            "assessment": "Naltrexone, the usual first choice, cannot be used with buprenorphine. Acamprosate is safe with buprenorphine and with her normal kidney function; topiramate is a second choice. Her withdrawal risk is low, so she does not need a medically managed withdrawal"
          },
          {
            "display": "Liver",
            "assessment": "AST higher than ALT with a raised GGT and a high MCV points to alcohol. Albumin, bilirubin, and platelets are normal, and FIB-4 is 1.18, below 1.3, so advanced fibrosis is unlikely and elastography is not needed now. Repeating liver tests as drinking changes, and FIB-4 within a year, is enough. She is not immune to hepatitis B and should complete the series"
          },
          {
            "display": "Return to use",
            "assessment": "A return to use is common and is a reason to strengthen treatment, not to stop it. Her greatest risk is a gap in her medication while touring"
          }
        ],
        "recommendations": [
          "Increase buprenorphine with naloxone to 16 mg once daily today",
          "Start acamprosate 666 mg three times daily; continue thiamine while she drinks heavily",
          "Naloxone at home and in her bag, with her friend trained; fentanyl test strips; never use alone",
          "Visits every one to two weeks for the first month, then every two to four weeks until stable, then monthly; telehealth check-ins when she is on tour",
          "Urine drug testing with fentanyl at most visits early on, explained as part of care, never as a condition of treatment; check the prescription drug monitoring program before each prescription",
          "PEth with liver tests at each check while she is drinking; FIB-4 again at six to twelve months; elastography only if FIB-4 reaches 1.3",
          "Complete the hepatitis A and B vaccine series; repeat hepatitis C and HIV testing yearly while any drug use continues",
          "If she returns to use, keep her on buprenorphine, increase support, and look for the cause; consider monthly extended-release buprenorphine if gaps in supply recur",
          "Plan for tours before each trip: a pharmacy chain that can fill in any state, prior authorization kept current, an early fill, and a travel letter",
          "Offer counseling and peer recovery support without making them a condition of medication"
        ],
        "communication": "Discussed with Dr. Mayfield, who sees her the same day. The plan was explained to Ms. Holiday, who agreed with it; at her request this note is shared only with Dr. Mayfield and is held under the federal confidentiality rule for substance use disorder records",
        "follow_up": "Addiction medicine review at three months or sooner if there is a return to use; Dr. Mayfield continues prescribing"
      },
      "guideline_ids": [
        "GL-ASAM-OUD-2020",
        "GL-SAMHSA-MOUD",
        "GL-SUD-2021",
        "GL-AASLD-ALD-2019",
        "GL-AASLD-NIT-2025",
        "GL-CDC-HBV-2023"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "She wants to stay off heroin and keep singing, and is afraid of losing her tolerance and overdosing",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to her documented wish to recover.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "She wants to drink less, especially around shows",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "She wants her records kept private and to be treated without judgment",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Stay on buprenorphine without interruption through six months, including through any return to use",
        "status": "completed",
        "target_date": "2026-10-19",
        "outcome": "Taking buprenorphine 16 mg daily at six months; a three-day gap during a tour was followed by a brief return to use and an immediate restart, with no overdose",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic retention goal; recovery is not required to be linear.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Naloxone at home and in her bag, and a friend trained to use it, by the one-week visit",
        "status": "completed",
        "target_date": "2026-04-27",
        "outcome": "Two naloxone two-packs dispensed; her friend trained",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic overdose-prevention goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Reduce drinking to PEth below 20 ng/mL, or to the level she chooses, by six months",
        "status": "completed",
        "target_date": "2026-10-19",
        "outcome": "PEth 22 ng/mL from 312; occasional light drinking, which she chose",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol goal set with her.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Hepatitis A and B vaccine series completed by six months",
        "status": "completed",
        "target_date": "2026-10-19",
        "outcome": "Hepatitis B doses at intake and five weeks; hepatitis A doses at intake and six months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "PHQ-9 score below 5 by six months",
        "status": "completed",
        "target_date": "2026-10-19",
        "outcome": "PHQ-9 4",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mood goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Buprenorphine with naloxone started in primary care at a low first dose, then 16 mg daily, continued through any return to use; naloxone, overdose education, never using alone, and fentanyl test strips",
        "status": "completed",
        "guideline_ids": [
          "GL-ASAM-OUD-2020",
          "GL-SAMHSA-MOUD",
          "GL-SUD-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic medication and overdose-prevention plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Addiction medicine consultation to confirm the medication plan, choose a medicine for alcohol use disorder that can be used with buprenorphine, and set the monitoring plan",
        "status": "completed",
        "guideline_ids": [
          "GL-ASAM-OUD-2020",
          "GL-SUD-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Alcohol care: acamprosate, thiamine, brief counseling and goals she chooses, and PEth at each check to follow drinking without relying on memory",
        "status": "completed",
        "guideline_ids": [
          "GL-SUD-2021",
          "GL-SAMHSA-MOUD"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic alcohol plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "recorded_date": "2026-04-27"
      },
      {
        "id": "INT-004",
        "display": "Liver and infection screening: liver tests and FIB-4 at intake and six months, hepatitis C antibody, hepatitis B triple panel, and HIV test, with hepatitis A and B vaccines for a person who is not immune",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-ALD-2019",
          "GL-AASLD-NIT-2025",
          "GL-CDC-HBV-2023",
          "GL-USPSTF-HCV-2020",
          "GL-USPSTF-HIV-2019"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver and infection plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Depression screening with the PHQ-9 at each recovery visit, a structured safety assessment with a written safety plan and the 988 Suicide & Crisis Lifeline, and safety review at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-USPSTF-DEP-2023",
          "GL-SUICIDE-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mood and safety plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Integrated, trauma-informed recovery plan: weekly counseling, a peer recovery coach, confidentiality she controls, and a written plan for touring, without requiring recovery to be perfect or linear",
        "status": "completed",
        "guideline_ids": [
          "GL-SUD-2021",
          "GL-SAMHSA-MOUD"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic recovery plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T18:00:00-05:00"
        },
        "recorded_date": "2026-04-27"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-ASAM-OUD-2020",
        "title": "The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update",
        "publisher": "American Society of Addiction Medicine (Journal of Addiction Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32511106/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-SAMHSA-MOUD",
        "title": "Treatment Options for Substance Use Disorder (medications for opioid and alcohol use disorders)",
        "publisher": "Substance Abuse and Mental Health Services Administration",
        "url": "https://www.samhsa.gov/medications-substance-use-disorders",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-SUD-2021",
        "title": "VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://www.healthquality.va.gov/guidelines/MH/sud/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-AASLD-ALD-2019",
        "title": "Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases",
        "publisher": "American Association for the Study of Liver Diseases (Hepatology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/31314133/",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-AASLD-NIT-2025",
        "title": "AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis",
        "publisher": "American Association for the Study of Liver Diseases (Hepatology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38489523/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-CDC-HBV-2023",
        "title": "Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recommendations and Reports)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36893044/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-SUICIDE-2024",
        "title": "VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2024",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-STI-2021",
        "title": "Chlamydia and Gonorrhea: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-TOB-2021",
        "title": "Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-IPV-2018",
        "title": "Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-ADA-ABX-2019",
        "title": "Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling",
        "publisher": "American Dental Association (Journal of the American Dental Association)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/31668170/",
        "version_or_year": "2019"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the low first buprenorphine dose after enforced abstinence, acamprosate rather than naltrexone, and the FIB-4 interpretation."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "PBS American Masters, Biography.com, Clio (Saint Vincent College), the Jazz.com encyclopedia, and The Globe and Mail logged. The account of racially motivated targeting is graded R. Her autobiography was not fetched and is not quoted."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Substance-use claims are marked sensitive; person-first language throughout; arrests and custody recorded without judgment and never as her fault; the return to use is managed without blame or discharge; the safety assessment gives the 988 Suicide & Crisis Lifeline; death recorded without detail."
    }
  }
}
